Grants

Our Grantmaking in 2017

This total represents grant payment activity during the selected fiscal year. However, approximately 90% of the money awarded in our priority program areas is part of multi-year commitments, so a grant may appear in multiple years of activity. The list below provides additional information about specific projects approved and/or paid during the fiscal year selected, including the project start date and the length of our commitment.

  1. National Institutes of Health

    $585,000 through June 2022

    to study how to reduce chronic inflammation in MS patients. www.nih.gov

    Multiple Sclerosis USA Awarded: May 2017
  2. Regents of the University of Colorado

    $120,000 through June 2019

    to study mechanisms regulating MS-related myelin injury and repair in cortical lesions. www.ucdenver.edu

    Multiple Sclerosis USA Awarded: May 2017
  3. World Vision

    $800,000 through May 2018

    to support a strategic partnership with IRC to plan and implement comprehensive water projects in the planned district-based programs in Ghana, Mali and Niger. www.worldvision.org

    Safe Water International Awarded: May 2017
  4. Baylor College of Medicine

    $120,000 through June 2019

    to study how targeting the Wnt receptor complex may increase myelin repair in MS patients. www.bcm.edu

    Multiple Sclerosis USA Awarded: May 2017
  5. Jibu, L3C

    $1,000,000 through July 2027

    to make a program related investment (PRI) into Jibu, a social franchise providing safe water in Uganda and Mali.

    Safe Water International Awarded: May 2017
  6. Partnership for a Drug Free America

    $750,000 through June 2019

    to equip parents with resources to address youth substance use. www.drugfree.org

    Substance Use Prevention USA Awarded: May 2017
  7. Sisters of Mercy of the Americas

    $840,000 through December 2019

    to support programs and build organizational capacity of the inter-congregational Leadership Collaborative to prepare young sisters for leadership positions. www.sistersofmercy.org

    Catholic Sisters USA Awarded: May 2017
  8. PATH

    $8,200,000 through June 2021

    to scale up early childhood development services as part of health systems in Mozambique, Kenya, and Zambia. www.path.org

    Young Children Affected by HIV and AIDS International Awarded: May 2017
  9. The New York Opportunity Network, Inc.

    $500,000 through May 2018

    for general operating support to facilitate the organization's strategic growth plan. http://opportunitynetwork.org

    USA Awarded: May 2017
  10. Massachusetts General Hospital

    $120,000 through June 2019

    to develop imaging markers of axonal damage and myelin integrity in MS patients using ultra-high gradient MRI techniques. http://www.massgeneral.org/

    Multiple Sclerosis USA Awarded: May 2017
  11. Washington University

    $120,000 through June 2019

    to identify biomarkers in cerebrospinal fluid that may predict MS disease progression and responses to therapy. http://www.wustl.edu

    Multiple Sclerosis USA Awarded: May 2017
  12. Vanderbilt University Medical Center

    $120,000 through June 2019

    to apply advanced imaging to the study of the cervical spinal cord in patients with MS. https://ww2.mc.vanderbilt.edu/

    Multiple Sclerosis USA Awarded: May 2017
  13. Johns Hopkins University

    $120,000 through June 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  14. University of Southern California

    $120,000 through June 2019

    to study the potential of angiotensin 1-7 to promote oligodendrocyte progenitor cell remyelination. http://www.usc.edu

    Multiple Sclerosis USA Awarded: May 2017
  15. Icahn School of Medicine at Mount Sinai

    $395,000 through June 2022

    to study astrocytic regulation of immune cell activity during central nervous system inflammation. http://icahn.mssm.edu

    Multiple Sclerosis USA Awarded: May 2017
  16. Johns Hopkins University

    $620,000 through June 2022

    to use advanced imaging techniques to study what role astrocytes cells in the cortex may play in promoting remyelination in MS. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  17. University of California, San Francisco

    $120,000 through June 2019

    to study misfolded tau aggregates found in the brains of MS patients. http://www.ucsf.edu

    Multiple Sclerosis USA Awarded: May 2017
  18. Case Western Reserve University

    $120,000 through June 2018

    to study the unifying mechanisms all remyelinating molecules have in common and to share findings with the field of MS research. https://case.edu/

    Multiple Sclerosis USA Awarded: May 2017
  19. New York Stem Cell Foundation, Inc.

    $120,000 through June 2019

    to study the properties of oligodendrocyte progenitor cells in MS. http://www.nyscf.org

    Multiple Sclerosis USA Awarded: May 2017
  20. Regents of the University of California, Irvine

    $120,000 through June 2019

    to study whether lower GlcNAc levels promote the progression of MS by preventing oligodendrocyte formation and reducing remyelination. http://www.research.uci.edu/about/index.html

    Multiple Sclerosis USA Awarded: May 2017